Pilar Nozal
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Prevalence of non-HLA antibodies and their association with FIB-4 index-based fibrosis risk in pediatric liver transplant recipients with long-term graft survival (>10 years).
Journal: Frontiers in immunology
Published: February 19, 2026
Extracellular Vesicles as Novel Biomarkers for Tumor Association in Intermediate-Risk Paraneoplastic Neurologic Syndromes.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 10, 2025
Positive predictive values of enzyme-linked immunosorbent assay (ELISA) for antienvoplakin and anticollagen VII antibodies: Results from 4 centers from Spain.
Journal: Journal of the American Academy of Dermatology
Published: July 30, 2025
Influence of rheumatoid factor levels and TNF inhibitor structure on secondary nonresponse in rheumatoid arthritis patients.
Journal: Frontiers in medicine
Published: July 08, 2024
Trends in Faecal Zonulin Concentrations in Paediatric Patients with Celiac Disease at Baseline and on a Gluten-Free Diet: Exploring Correlations with Other Faecal Biomarkers.
Journal: Nutrients
Published: January 31, 2024
Clinical Characteristics of Patients With Acquired Partial Lipodystrophy: A Multicenter Retrospective Study.
Journal: The Journal of clinical endocrinology and metabolism
Published: July 14, 2023
Influence of rheumatoid factor on serum drug levels of TNF inhibitors with different structures in rheumatoid arthritis.
Journal: Clinical and experimental rheumatology
Published: May 30, 2023
Dual role of peripheral B cells in multiple sclerosis: emerging remote players in demyelination and novel diagnostic biomarkers.
Journal: Frontiers in immunology
Published: May 17, 2023
Immune response after SARS-CoV-2 vaccination in patients with inflammatory immune-mediated diseases receiving immunosuppressive treatment.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: April 24, 2023
Early monitoring of anti-infliximab antibodies by drug-tolerant assay predicts later immunogenicity and drug survival in rheumatic diseases.
Journal: Rheumatology (Oxford, England)
Published: March 02, 2023
Last Updated: 09/26/2026